Team:ETH Zurich/lab/safety

From 2014.igem.org

(Difference between revisions)
(Risks to the safety and health of the general public and the environment)
(Measures to reduce the risks mentioned above)
Line 61: Line 61:
<br>
<br>
<br>
<br>
-
The risk of our project for the environment, public and also the people working in the laboratory has already been minimized when choosing the organism. As the E. coli strains used by the team belong to Risk level 1 organism no harm for human, animals and environment is to be expected.
+
The risk of our project for the environment, public and also the people working in the laboratory has already been minimized when choosing the organism. As the ''E. coli'' strains used by the team belong to Risk level 1 organism no harm for human, animals and environment is to be expected.
<html></article></html>
<html></article></html>
<html><article></html>
<html><article></html>
 +
== Future Risks and risk-reducing features ==
== Future Risks and risk-reducing features ==
The way our project is planned we do not intend any industrial, therapeutic, diagnostic or medicinal purposes or applications and so the organisms will be restricted to laboratory environments only. Moreover we see our project as a beginning or foundation and advancement will take time. Therefore it is difficult to envision scenarios where severe dangers are encountered. A possible scenario in the distant future could be that someone modifies our methods and use them with organisms/genes that pose greater risks than the non-pathogenic E. coli.  As the team has only used standard molecular biological methods and protocols that can be conducted in any laboratory fulfilling at least safety level 1 we see no new risks to personal, environmental and public safety arising from our project becoming more popular.
The way our project is planned we do not intend any industrial, therapeutic, diagnostic or medicinal purposes or applications and so the organisms will be restricted to laboratory environments only. Moreover we see our project as a beginning or foundation and advancement will take time. Therefore it is difficult to envision scenarios where severe dangers are encountered. A possible scenario in the distant future could be that someone modifies our methods and use them with organisms/genes that pose greater risks than the non-pathogenic E. coli.  As the team has only used standard molecular biological methods and protocols that can be conducted in any laboratory fulfilling at least safety level 1 we see no new risks to personal, environmental and public safety arising from our project becoming more popular.

Revision as of 15:01, 14 October 2014

iGEM ETH Zurich 2014